Abbott, Johnson & Johnson Market Share in Tubeless Insulin Pump Market|Key Players: Insulet Corporation, Medtrum Technologies Inc., Cellnovo Group SA, Valeritas, Spring Health, Debiotech SA, CeQur

Rising number of diabetic and obese patients coupled with introduction of advanced pump will serve as high impact rendering factors for the tubeless insulin pump market growth. Advent of new technologies in continuous glucose monitoring without the need for daily insulin injection doses will stimulate business growth over the forecast years. Growing adoption of minimally invasive insulin delivery methods should improve patient compliance. Inadequate reimbursement coverage and high long-term cost associated with tubeless insulin pump will hamper its adoption in emerging economies. Compliance to insulin therapy may reduce owing to high maintenance therapy cost.

Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2032

Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:

1.Abbott
2.Johnson & Johnson
3.Insulet Corporation
4.Medtrum Technologies Inc.
5.Cellnovo Group SA
6.Valeritas
7.Spring Health
8.Debiotech SA
9.CeQur

Tubeless insulin pump remote should grow in parallel with the pods segment. Although the replacement rate of remotes is not as high as that of pods, their initial capital requirement is higher. Increasing sales of new tubeless insulin pump will fuel the significant growth of the remote market. Distribution of tubeless insulin pump through e-commerce platforms has become the most popular medium. In 2016, e-commerce held the market share of over 50%, valuing more than USD 250 million. This online platform will witness a significant growth over the forecast period. Distribution through hospitals is less preferred medium because of the high cost of tubeless insulin pump. However, many private hospitals have recently started offering tubeless insulin pump at affordable prices, augmenting the industry growth of the tubeless insulin pump market.

U.S. tubeless insulin pump market valued over USD 200 million in 2016 and anticipated to grow significantly over the coming years. Switching of insulin pump user from tubed to tubeless should be the major growth rendering factor. Moreover, increasing adoption of tubeless pump by first time users will fuel regional industry growth. Germany tubeless insulin pump market accounted for more than 20% of overall regional revenue share, owing to increasing number of diabetic patients and advanced healthcare system. Growing adoption of advanced technology will drive rapid industry grow over the forecast years.

Japan tubeless insulin pump market accounted for largest regional revenue share owing to its growing trend to adopt advanced technology. Rising per capita income of diabetic patients and high healthcare expenditure will promote tubeless insulin pump market growth.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2032

Tubeless insulin Pump market by component
o Pod/Patch
o Remote

Tubeless insulin Pump market by distribution channel
o Hospitals
o Pharmacies
o E-commerce

Global Market Insights Inc. is a global market research and management consulting company catering to leading corporations, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

Global Market Insights, Inc.
4 North Main Street
Selbyville, Delaware 19975 USA
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email:sales@gminsights.com

This release was published on openPR.